2009-11-12 18:30:03 CET

2009-11-12 18:31:35 CET


REGULATED INFORMATION

English
Össur hf. - Company Announcement

Correction: wrong date in the previous announcement - Össur signs a new market making agreement with Saga Capital



Press release from Ossur hf.
                                          12 November 2009, GMT 17:00





           Össur signs a new market making agreement with
                            Saga Capital


Össur hf. and Saga  Capital Investment Bank hf.  have today signed  a
new market making agreement, replacing the previous agreement between
the companies from April 2008. This agreement is only in relation  to
the Company's listing in Iceland.

According to  the agreement,  Saga Capital  acts as  market maker  on
NASDAQ OMX  Iceland for  shares issued  by Össur.  Saga Capital  will
submit daily bid and  offer quotes for the  shares in the NASDAQ  OMX
Iceland trading system. The amount of each bid and offer quote  shall
be a minimum of 20,000 shares  at a price determined by Saga  Capital
at any given time. The maximum bid/offer spread shall not exceed 2.0%
and the difference from  the last price shall  not exceed 3.5%.  Saga
Capital is obligated to  provide liquidity for  up to 100,000  shares
each day.

The purpose of  the agreement  is to facilitate  trading and  provide
liquidity in  the  Company's shares  on  NASDAQ OMX  Iceland  and  to
promote efficient and transparent price formation.




Össur contacts:
Hjörleifur Palsson, CFO, tel. +354 515 1300
Sigurborg Arnarsdottir, IR Manager, tel. +354 664 1044






About Össur
Össur (OMX: OSSR)  is a  global leader  in non-invasive  orthopaedics
that help people  live a  life without limitations.  Its business  is
focused on  improving  people's  mobility  through  the  delivery  of
innovative technologies within  the fields of  bracing and  supports,
prosthetic limbs and compression therapies. A recognized  "Technology
Pioneer",  Össur  invests  significantly  in  research  and   product
development; its award-winning designs ensuring a consistently strong
position in the market. Successful patient and clinical outcomes  are
further empowered  via  Össur's  educational  programs  and  business
solutions. Headquartered in  Iceland, Össur has  major operations  in
America and Europe, with additional distributors worldwide.